Edition:
India

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
2:29am IST
Change (% chg)

$-0.03 (-1.46%)
Prev Close
$2.06
Open
$2.05
Day's High
$2.10
Day's Low
$2.01
Volume
58,458
Avg. Vol
85,888
52-wk High
$7.26
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Boxer Capital Reports 5.9 Pct Passive Stake In Aradigm Corp As Of Nov 30
Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - Aradigm Corp ::BOXER CAPITAL LLC REPORTS 5.9 PERCENT PASSIVE STAKE IN ARADIGM CORP AS OF NOVEMBER 30 - SEC FILING.  Full Article

Aradigm Q3 loss per share $0.26
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Aradigm Corp :Aradigm announces third quarter 2017 financial results.Q3 loss per share $0.26.Aradigm corp - qtrly ‍rev $2.7 million versus $50,000​.  Full Article

Aradigm reports Q2 loss per share $0.59
Wednesday, 10 Aug 2016 

Aradigm Corp : Aradigm announces second quarter 2016 financial results . Q2 loss per share $0.59 .Qtrly revenue $14,000 versus $10 million in Q2 of 2015.  Full Article

Aradigm posts Q1 loss per share $0.55
Tuesday, 10 May 2016 

Aradigm Corp : Aradigm announces first quarter 2016 financial results . Q1 loss per share $0.55 .Says recorded $6,000 in revenue in Q1 of 2016 compared with $8.8 million in revenue in Q1 of 2015.  Full Article

Aradigm Corp prices private placement of senior notes
Friday, 22 Apr 2016 

Aradigm Corp:Says pricing of $23 million of its senior convertible notes due 2021.Intends to use the net proceeds from the offering to fund the current clinical development and regulatory submission for licensure of Pulmaquin and for general corporate purposes.  Full Article

BRIEF-Aradigm - FDA Advisory Committee Did Not Recommend Approval For Linhaliq

* ARADIGM REPORTS RESULTS OF FDA ADVISORY COMMITTEE MEETING ON LINHALIQ‍​